The retrospective analysis of the current cohort of 24 patients based on risk stratification using the 7-point PLASMIC score confirmed the role of clinical assessment in the timely detection of severe ADAMTS13 deficiency in adult patients with TMA. This evidence concerns the gene ADAMTS13 and hyperinsulinemic hypoglycemia, familial, 4.